It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
The canonical G406R mutation that increases Ca2+ influx through the CACNA1C-encoded CaV1.2 Ca2+ channel underlies the multisystem disorder Timothy syndrome (TS), characterized by life-threatening arrhythmias. Severe episodic hypoglycemia is among the poorly characterized non-cardiac TS pathologies. While hypothesized from increased Ca2+ influx in pancreatic beta cells and consequent hyperinsulinism, this hypoglycemia mechanism is undemonstrated because of limited clinical data and lack of animal models. We generated a CaV1.2 G406R knockin mouse model that recapitulates key TS features, including hypoglycemia. Unexpectedly, these mice do not show hyperactive beta cells or hyperinsulinism in the setting of normal intrinsic beta cell function, suggesting dysregulated glucose homeostasis. Patient data confirm the absence of hyperinsulinism. We discover multiple alternative contributors, including perturbed counterregulatory hormone responses with defects in glucagon secretion and abnormal hypothalamic control of glucose homeostasis. These data provide new insights into contributions of CaV1.2 channels and reveal integrated consequences of the mutant channels driving life-threatening events in TS.
Gain of function mutant CaV1.2 channels drive life-threatening hypoglycemia in the multisystem disorder Timothy syndrome, but the underlying mechanisms are unknown. Here the authors show the mutant channels have adverse effects on counterregulatory hormones and CNS control of glucose homeostasis.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details





1 Weill Cornell Medicine, Cardiovascular Research Institute, New York, USA (GRID:grid.471410.7) (ISNI:0000 0001 2179 7643)
2 Weill Cornell Medicine, Cardiovascular Research Institute, New York, USA (GRID:grid.471410.7) (ISNI:0000 0001 2179 7643); Weill Cornell Medicine, Weill Center for Metabolic Health, New York, USA (GRID:grid.471410.7) (ISNI:0000 0001 2179 7643)
3 Duke University Medical Center, Department of Medicine, MSRB II, 2 Genome Ct, Durham, USA (GRID:grid.189509.c) (ISNI:0000000100241216)
4 Weill Cornell Medicine, Weill Center for Metabolic Health, New York, USA (GRID:grid.471410.7) (ISNI:0000 0001 2179 7643)
5 Columbia University, Division of Cardiology, Department of Medicine, Vagelos College of Physicians and Surgeons, New York, USA (GRID:grid.21729.3f) (ISNI:0000 0004 1936 8729); Columbia University, Department of Pharmacology, Vagelos College of Physicians and Surgeons, New York, USA (GRID:grid.21729.3f) (ISNI:0000 0004 1936 8729)
6 Weill Cornell Medical College, Department of Biochemistry, New York, USA (GRID:grid.5386.8) (ISNI:000000041936877X)
7 Cook Children’s Medical Center, Division of Endocrinology and Diabetes, Fort Worth, USA (GRID:grid.413584.f) (ISNI:0000 0004 0383 5679)
8 Harvard Medical School, Children’s Hospital Boston, Boston, USA (GRID:grid.38142.3c) (ISNI:000000041936754X)
9 Weill Cornell Medicine, Cardiovascular Research Institute, New York, USA (GRID:grid.471410.7) (ISNI:0000 0001 2179 7643); Weill Cornell Medicine, Weill Center for Metabolic Health, New York, USA (GRID:grid.471410.7) (ISNI:0000 0001 2179 7643); Weill Cornell Medicine, Division of Cardiology, Department of Medicine, New York, USA (GRID:grid.471410.7) (ISNI:0000 0001 2179 7643)